Literature DB >> 30201808

Phenotypic and Functional Signatures of Herpes Simplex Virus-Specific Effector Memory CD73+CD45RAhighCCR7lowCD8+ TEMRA and CD73+CD45RAlowCCR7lowCD8+ TEM Cells Are Associated with Asymptomatic Ocular Herpes.

Ruchi Srivastava1, Pierre-Grégoire Coulon1, Soumyabrata Roy1, Sravya Chilukuri1, Sumit Garg1, Lbachir BenMohamed2,3,4.   

Abstract

HSV type 1 (HSV-1)-specific CD8+ T cells protect from herpes infection and disease. However, the nature of protective CD8+ T cells in HSV-1 seropositive healthy asymptomatic (ASYMP) individuals (with no history of clinical herpes disease) remains to be determined. In this study, we compared the phenotype and function of HSV-specific CD8+ T cells from HLA-A*02:01-positive ASYMP and symptomatic (SYMP) individuals (with a documented history of numerous episodes of recurrent ocular herpetic disease). We report that although SYMP and ASYMP individuals have similar frequencies of HSV-specific CD8+ T cells, the "naturally" protected ASYMP individuals have a significantly higher proportion of multifunctional HSV-specific effector memory CD8+ T cells (CD73+CD45RAhighCCR7lowCD8+ effector memory RA (TEMRA) and CD73+CD45RAlowCCR7lowCD8+ effector memory (TEM) as compared with SYMP individuals. Similar to humans, HSV-1-infected ASYMP B6 mice had frequent multifunctional HSV-specific CD73+CD8+ T cells in the cornea, as compared with SYMP mice. Moreover, in contrast to wild type B6, CD73-/- deficient mice infected ocularly with HSV-1 developed more recurrent corneal herpetic infection and disease. This was associated with less functional CD8+ T cells in the cornea and trigeminal ganglia, the sites of acute and latent infection. The phenotypic and functional characteristics of HSV-specific circulating and in situ CD73+CD8+ T cells, demonstrated in both ASYMP humans and mice, suggest a positive role for effector memory CD8+ T cells expressing the CD73 costimulatory molecule in the protection against ocular herpes infection and disease. These findings are important for the development of safe and effective T cell-based herpes immunotherapy.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30201808      PMCID: PMC6195422          DOI: 10.4049/jimmunol.1800725

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  85 in total

1.  Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.

Authors:  Emanuela M Iancu; Patricia Corthesy; Petra Baumgaertner; Estelle Devevre; Verena Voelter; Pedro Romero; Daniel E Speiser; Nathalie Rufer
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

2.  A2A adenosine receptor protects tumors from antitumor T cells.

Authors:  Akio Ohta; Elieser Gorelik; Simon J Prasad; Franca Ronchese; Dmitriy Lukashev; Michael K K Wong; Xiaojun Huang; Sheila Caldwell; Kebin Liu; Patrick Smith; Jiang-Fan Chen; Edwin K Jackson; Sergey Apasov; Scott Abrams; Michail Sitkovsky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-17       Impact factor: 11.205

Review 3.  Topical/mucosal delivery of sub-unit vaccines that stimulate the ocular mucosal immune system.

Authors:  Anthony B Nesburn; Ilham Bettahi; Xiuli Zhang; Xiaoming Zhu; Winston Chamberlain; Rasha E Afifi; Steven L Wechsler; Lbachir BenMohamed
Journal:  Ocul Surf       Date:  2006-10       Impact factor: 5.033

4.  Targeting the genital tract mucosa with a lipopeptide/recombinant adenovirus prime/boost vaccine induces potent and long-lasting CD8+ T cell immunity against herpes: importance of MyD88.

Authors:  Xiuli Zhang; Xavier Dervillez; Aziz Alami Chentoufi; Tina Badakhshan; Ilham Bettahi; Lbachir Benmohamed
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

5.  Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

Authors:  Lbachir BenMohamed; Georges Bertrand; Cory D McNamara; Helene Gras-Masse; Juergen Hammer; Steven L Wechsler; Anthony B Nesburn
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge.

Authors:  X Zhang; A A Chentoufi; G Dasgupta; A B Nesburn; M Wu; X Zhu; D Carpenter; S L Wechsler; S You; L BenMohamed
Journal:  Mucosal Immunol       Date:  2008-12-24       Impact factor: 7.313

7.  CD73 expression in RPE cells is associated with the suppression of conventional CD4 cell proliferation.

Authors:  Song Chen; Shumin Zhou; Kai Zang; Fanqiang Kong; Dongchun Liang; Hua Yan
Journal:  Exp Eye Res       Date:  2014-05-28       Impact factor: 3.467

8.  Increased TNF-α/IFN-γ/IL-2 and Decreased TNF-α/IFN-γ Production by Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis Following BCG Vaccination.

Authors:  Mayara F Maggioli; Mitchell V Palmer; Tyler C Thacker; Hans Martin Vordermeier; Jodi L McGill; Adam O Whelan; Michelle H Larsen; William R Jacobs; W Ray Waters
Journal:  Front Immunol       Date:  2016-10-17       Impact factor: 7.561

9.  Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition.

Authors:  Jia Zhu; Florian Hladik; Amanda Woodward; Alexis Klock; Tao Peng; Christine Johnston; Michael Remington; Amalia Magaret; David M Koelle; Anna Wald; Lawrence Corey
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

10.  CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help.

Authors:  Yusuke Nakanishi; Bao Lu; Craig Gerard; Akiko Iwasaki
Journal:  Nature       Date:  2009-11-08       Impact factor: 49.962

View more
  5 in total

1.  Antiviral CD19+CD27+ Memory B Cells Are Associated with Protection from Recurrent Asymptomatic Ocular Herpesvirus Infection.

Authors:  Nisha R Dhanushkodi; Swayam Prakash; Ruchi Srivastava; Pierre-Gregoire A Coulon; Danielle Arellano; Rayomand V Kapadia; Raian Fahim; Berfin Suzer; Leila Jamal; Hawa Vahed; Lbachir BenMohamed
Journal:  J Virol       Date:  2022-01-05       Impact factor: 6.549

2.  Therapeutic Mucosal Vaccination of Herpes Simplex Virus 2-Infected Guinea Pigs with Ribonucleotide Reductase 2 (RR2) Protein Boosts Antiviral Neutralizing Antibodies and Local Tissue-Resident CD4+ and CD8+ TRM Cells Associated with Protection against Recurrent Genital Herpes.

Authors:  Ruchi Srivastava; Soumyabrata Roy; Pierre-Gregoire Coulon; Hawa Vahed; Swayam Prakash; Nisha Dhanushkodi; Grace J Kim; Mona A Fouladi; Joe Campo; Andy A Teng; Xiaowu Liang; Hubert Schaefer; Lbachir BenMohamed
Journal:  J Virol       Date:  2019-04-17       Impact factor: 6.549

3.  NLRP3, NLRP12, and IFI16 Inflammasomes Induction and Caspase-1 Activation Triggered by Virulent HSV-1 Strains Are Associated With Severe Corneal Inflammatory Herpetic Disease.

Authors:  Pierre-Gregoire Coulon; Nisha Dhanushkodi; Swayam Prakash; Ruchi Srivastava; Soumyabrata Roy; Nuha I Alomari; Angela M Nguyen; Wasay R Warsi; Caitlin Ye; Edgar A Carlos-Cruz; Uyen T Mai; Audrey C Cruel; Keysi M Ekmekciyan; Eric Pearlman; Lbachir BenMohamed
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 8.786

4.  Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration.

Authors:  Rafiq Nabi; Andrew C Lewin; Therese M Collantes; Vladimir N Chouljenko; Konstantin G Kousoulas
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

5.  Upregulation of Multiple CD8+ T Cell Exhaustion Pathways Is Associated with Recurrent Ocular Herpes Simplex Virus Type 1 Infection.

Authors:  Pierre-Grégoire Coulon; Soumyabrata Roy; Swayam Prakash; Ruchi Srivastava; Nisha Dhanushkodi; Stephanie Salazar; Cassandra Amezquita; Lan Nguyen; Hawa Vahed; Angela M Nguyen; Wasay R Warsi; Caitlin Ye; Edgar A Carlos-Cruz; Uyen T Mai; Lbachir BenMohamed
Journal:  J Immunol       Date:  2020-06-15       Impact factor: 5.426

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.